David McGovern joined SomaLogic in 2021 as Senior Vice President of Marketing. He has over 25 years of diverse marketing and commercial leadership experience in executive positions within the life science and healthcare industry.
Mr. McGovern joined SomaLogic from Pfizer, where he led U.S. payer strategic marketing for a specialty portfolio representing over $5 billion in annual revenue. He previously served as Vice President of Marketing and Business Development at Change Healthcare. In this role, he led a marketing organization focused on driving innovative healthcare software, analytics and service solutions for Change Healthcare’s Software and Analytics division, whose primary customers included the leading health insurance organizations and integrated delivery networks within the U.S. market. He also led the business development activities, including partnership identification, analytics and deal development for one of the largest technology units within Change Healthcare. Prior to Change Healthcare, Mr. McGovern held various leadership positions in global commercial development, product marketing and market access for several multinational biotechnology organizations, including Johnson & Johnson, Merck and Otsuka. He also served as Vice President of Marketing for Nupathe Inc, which was successfully sold to Teva Pharmaceuticals.
Mr. McGovern received his MBA from Villanova University and bachelor’s degree from Drexel University.